Michelle Stewart Selected Research

tafamidis

8/2022	Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies.
1/2022	Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary.
1/2021	Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
12/2020	Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.
6/2020	Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years.
1/2020	The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
9/2018	Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
6/2018	Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
9/2017	Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.
3/2017	Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle Stewart Research Topics

Disease

9	Cardiomyopathies (Cardiomyopathy) 08/2022 - 09/2018
6	Amyloid Neuropathies (Amyloid Neuropathy) 10/2021 - 03/2017
3	Heart Failure 01/2022 - 05/2015
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021 - 04/2015
3	Transthyretin-Related Hereditary Amyloidosis 06/2020 - 06/2018
3	Polyneuropathies (Polyneuropathy) 06/2020 - 09/2017
3	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 06/2018 - 03/2017
3	Psychotic Disorders (Schizoaffective Disorder) 03/2013 - 12/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2014
2	Hypocalcemia 10/2020 - 01/2017
2	Weight Gain 01/2020 - 03/2011
2	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 10/2019 - 01/2019
2	Disease Progression 06/2018 - 03/2017
2	Huntington Disease (Huntington's Disease) 01/2018 - 02/2012
2	type 1 familial Hypocalciuric hypercalcemia 10/2017 - 05/2017
2	Neoplasms (Cancer) 01/2017 - 05/2014
2	Human Influenza (Influenza) 03/2013 - 01/2011
2	Schizophrenia (Dementia Praecox) 03/2011 - 12/2009
1	Frontotemporal Dementia (Semantic Dementia) 12/2021
1	Amyloidosis 11/2021
1	Rare Diseases (Rare Disease) 10/2021
1	Diabetes Mellitus 01/2020
1	COVID-19 01/2020
1	Cognitive Dysfunction 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 10/2017
1	Glucose Intolerance 01/2017
1	Hyperglycemia 01/2017
1	Epilepsy (Aura) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Hyperkinesis 01/2016
1	Erythema 02/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2015
1	Pruritus (Itching) 02/2015
1	Asthma (Bronchial Asthma) 12/2014
1	Myotonia 12/2014
1	Paralysis (Palsy) 12/2014
1	Channelopathies 12/2014
1	Communicable Diseases (Infectious Diseases) 03/2013
1	Parkinson Disease (Parkinson's Disease) 02/2012
1	Weight Loss (Weight Reduction) 02/2012
1	Tremor (Tremors) 02/2012
1	Mood Disorders (Mood Disorder) 03/2011
1	Infections 01/2011
1	Influenza in Birds (Avian Flu) 01/2011
1	Mania (Manias) 12/2009

Drug/Important Bio-Agent (IBA)

17	Prealbumin (Transthyretin)IBA 08/2022 - 03/2017
10	tafamidisIBA 08/2022 - 03/2017
8	Amyloid (Amyloid Fibrils)IBA 08/2022 - 09/2018
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2014
4	Calcium-Sensing ReceptorsIBA 10/2017 - 01/2017
2	CalciumIBA 10/2020 - 10/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2011
2	AMPA Receptors (AMPA Receptor)IBA 01/2019 - 01/2016
2	GTP-Binding Proteins (G-Protein)IBA 10/2017 - 01/2017
2	Parathyroid Hormone (Parathormone)IBA 10/2017 - 01/2017
2	VaccinesIBA 03/2013 - 01/2011
2	ziprasidone (Geodon)FDA Link 03/2011 - 12/2009
2	Monoclonal AntibodiesIBA 01/2011 - 09/2008
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	InotersenIBA 01/2020
1	patisiranIBA 01/2020
1	NADP TranshydrogenasesIBA 01/2020
1	WDB002IBA 01/2020
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	ferric citrate iron reductase (ferric-chelate reductase)IBA 01/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	polyglutamineIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Cinacalcet (Sensipar)FDA Link 10/2017
1	Sigma FactorIBA 05/2017
1	ClathrinIBA 05/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Superoxide Dismutase-1IBA 04/2015
1	Prostaglandins AIBA 02/2015
1	tofacitinibIBA 02/2015
1	Janus Kinase InhibitorsIBA 02/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 12/2014
1	NAV1.4 Voltage-Gated Sodium ChannelIBA 12/2014
1	pazopanib FDA Link 05/2014
1	Everolimus FDA Link 05/2014
1	Protein AggregatesIBA 01/2014
1	Subunit VaccinesIBA 03/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	AntigensIBA 03/2013
1	SynucleinsIBA 02/2012
1	Antipsychotic Agents (Antipsychotics)IBA 03/2011
1	Quetiapine Fumarate (Seroquel)FDA Link 03/2011
1	Neuraminidase (Sialidase)IBA 01/2011
1	Zanamivir (Relenza)FDA Link 01/2011

Therapy/Procedure

5	Therapeutics 12/2021 - 05/2014
2	Precision Medicine 01/2017 - 05/2014
1	Oral Administration 01/2017
1	Cardiac Rehabilitation 05/2015
1	Secondary Prevention 05/2015